GLSI (Greenwich LifeSciences) OCF Yield %: -4.03 (As of Jun. 25, 2026)


GLSI Greenwich LifeSciences Inc GLSI
33 GF Score
Price $21.63
! 1 Warning Sign
View Full Analysis

What is Greenwich LifeSciences OCF Yield %?

Greenwich LifeSciences GLSI +0.49% 33 OCF Yield % is -4.03 as of Jun. 25, 2026. GuruFocus rates GLSI with a GF Score™ of 33/100. The stock has 1 warning sign investors should review. Among 1,419 Biotechnology companies, Greenwich LifeSciences ranks better than 61.38% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Greenwich LifeSciences's Trailing 12-Month Cash Flow from Operations is $-12.78 Mil, and Market Cap is $317.49 Mil. Therefore, Greenwich LifeSciences's OCF Yield % for today is -4.03%.

The historical rank and industry rank for Greenwich LifeSciences's OCF Yield % or its related term are showing as below:

GLSI' s OCF Yield % Range Over the Past 10 Years
Min: -4.05   Med: 0   Max: -3.94
Current: -4.03

During the past 8 years, the highest OCF Yield % of Greenwich LifeSciences was -3.94%. The lowest was -4.05%. And the median was %.

GLSI's OCF Yield % is ranked better than
61.38% of 1419 companies
in the Biotechnology industry
Industry Median: -8.46 vs GLSI: -4.03

Greenwich LifeSciences's OCF Margin % for the quarter that ended in Mar. 2026 was %.

Greenwich LifeSciences OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Greenwich LifeSciences OCF Yield % Related Terms

Greenwich LifeSciences OCF Yield % Historical Data

* Premium members only.

The historical data trend for Greenwich LifeSciences's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Greenwich LifeSciences OCF Yield % Chart

Greenwich LifeSciences Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial -1.34 -3.17 -4.79 -4.92 -3.30

Greenwich LifeSciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -5.83 -7.31 -7.78 -4.23 -5.34

GLSI vs LRMR, RGNX, PBYI: OCF Yield % Comparison

For the Biotechnology subindustry, Greenwich LifeSciences's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Greenwich LifeSciences OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Greenwich LifeSciences's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Greenwich LifeSciences's OCF Yield % falls into.


GLSI
33GF Score
Greenwich LifeSciences Inc GLSI
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Greenwich LifeSciences OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Greenwich LifeSciences's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-9.913 / 300.40098
=-3.30%

Greenwich LifeSciences's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-4.702 * 4 / 352.27732
=-5.34%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -4.03 mean?
Greenwich LifeSciences (GLSI) has a OCF Yield % of -4.03 as of Jun. 25, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Greenwich LifeSciences and its competitors. According to the industry distribution chart, Greenwich LifeSciences ranks #548 out of 1419 companies in the Biotechnology industry, placing it in the top 38.6%.
Is Greenwich LifeSciences' OCF Yield % too high?
Greenwich LifeSciences' current OCF Yield % is -4.03. Based on the distribution chart, Greenwich LifeSciences ranks #548 out of 1419 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Greenwich LifeSciences has a GF Score™ of 33/100, reflecting its overall financial health beyond just this single metric.
How does Greenwich LifeSciences' OCF Yield % compare to LRMR and RGNX?
According to the Biotechnology industry distribution chart, Greenwich LifeSciences ranks #548 out of 1419 companies for OCF Yield %. This puts Greenwich LifeSciences in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Greenwich LifeSciences and its competitors. Greenwich LifeSciences's current OCF Yield % is -4.03. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Greenwich LifeSciences stock overvalued right now?
Greenwich LifeSciences (GLSI) has a current OCF Yield % of -4.03. The current OCF Yield % is -4.03. Greenwich LifeSciences' overall GF Score™ is 33/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Greenwich LifeSciences (GLSI), the current OCF Yield % is -4.03 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Greenwich LifeSciences Business Description

Address 3992 Bluebonnet Drive, Building 14, Stafford, TX, USA, 77477
Greenwich LifeSciences Inc a clinical-stage biopharmaceutical company focused on its Phase III clinical trial, Flamingo-01, which is evaluating GLSI-100, an immunotherapy to prevent breast cancer recurrences. GP2 is a 9 amino acid transmembrane peptide of the HER2/neu protein, a cell surface receptor protein that is expressed in a variety of common cancers, including expression in 75 percent of breast cancers at low (1+), intermediate (2+), and high (3+ or over-expressor) levels. The combination of GP2 + GM-CSF is called GLSI-100. The company is currently expanding Flamingo-01 into Europe with plans to open up to 150 sites globally.
33GF Score

Get the complete analysis for GLSI

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$21.63
Price